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Objectil·es. The aim of this study was to compare the myocardial retention of technetium·99m (Tc·99m) sestamibi and thaI· lium·2Ot over a wide range of blood flow at different time points after tracer injection.
Background. Technetium·99m sestamibi has been proposed as a new perfusion tracer with better physical characteristics than those of thallium·20t for scintigraphic imaging. Howeyer, no studies have simultaneously compared the ability of both tracers to assess myocardial. blood flow during pharmacologic l'asodila· tion.
Methods. The myocardial retention of Tc·99m sestamibi and thallium·20t were compared over a wide range of blood flow induced by regional coronary occlusion and dipyridamole infusion in an open chest dog model. Myocardial retention of both tracers was determined by in ,'itro tissue counting at 2, 5 and 20 min after tracer injection and was correlated with microsphere·determined blood flow.
Noninvasive evaluation of myocardial perfusion is most frequently performed by scintigraphic approaches with use of planar and tomographic imaging techniques. Although thallium-201 is the most widely applied single-photon agent for myocardial perfusion imaging, it is considered subopti· mal because of its low emission energy level (69 to 80 keY) and its long physical half-life of 72 h. To circumvent the physical limitations of thallium-201, technetium·99m (Tc-99m) derivatives have been proposed as alternative perfusion tracers (1,2). The higher emission energy of Tc-99m (140 keY) is better suited for camera characteristics and the shorter half-life of this agent allows larger injectable doses,
Results. Thallium·20t demonstrated greater absolute tissue retention than did Tc·99m sestamibi. At 2 min after tracer injection, there was an almost linear relation between the reten· tion of both tracers and myocardial blood flow O\'er a wide flow range. Howe\"er, this relation was not maintained over time. At 20 min after injection, the retention of both tracers underesti· mated myocardial blood flow at higher flow rates. At 2, 5 and 20 min after injection, increments of relatiye tracer retention between the different levels of flow were always greater for thallium·20t than for Tc·99m sestamibi.
Conclusions. Thallium·20t displays more suitable physiologic characteristics as a flow tracer and may allow better differentia· tion of myocardial regions with different levels of coronary flow reser\"e. For both tracers, early cardiac imaging may minimize underestimation of blood flow at higher flow rates.
(J Am Coil CardioI1992; 20:1277-83) thus improving image quality. In addition, Tc-99m derivatives are also appealing tracers because they allow simultaneous evaluation of myocardial blood flow and regional wall motion, which may increase the diagnostic specificity for detection of coronary artery disease. However, the fundamental kinetic requirement for a perfusion tracer is ability to accumulate in the myocardial tissue in proportion to the rate of coronary blood flow. This ability determines its accuracy as a myocardial perfusion tracer in nuclear cardiac imaging. This point has become particularly critical because the clinical use of coronary vasodilators (dipyridamole and adenosine, for example) results in a fourfold to fivefold increase of blood flow in normal vessel-related territories (3) (4) (5) (6) .
At present, two Tc-99m derivatives (technetium-99m sestamibi and technetium-99m teboroxime) are commercially available for clinical use. Tc-99m sestamibi, a lipophilic cationic Tc-99m complex, has been most widely evaluated in clinical trials (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . Although it achieves better image quality than that of thallium-201 (11) (12) (13) (14) , it has not been shown to provide higher diagnostic accuracy. It has been previously demonstrated in animal studies that Tc-99m sestamibi accumulates in the myocardium proportionally to regional blood flow (17) (18) (19) and that its myocardial clearance is slower than that of thallium·201 (20) (21) (22) (23) (24) extraction fraction decreases~s flow increases (20, 21) . Despite numerous studies defining the myocardial extraction and retention characteristics of thallium-201 and Tc-99m sestamibi, to our knowledge, no investigations have simultaneously compared the accuracy of both tracers in assessing myocardial blood flow during pharmacologic coronary vasodilation. Therefore, the purpose of the present study was to evaluate the myocardial retention characteristics of thallium-201 and Tc-99m sestamibi in comparison with those of microspheres over a wide range of blood flow at different intervals after injection.
Methods
This study protocol (Fig. I) was approved by the Committee for Animal Research at the University of Michigan and performed in accordance with the "Position of the American Heart Association on Research Animal Use" adopted November II, 1984 by the American Heart Association.
Experimental Preparation
Nine mongrel dogs (mean weight 19.3 ± 3.0 kg) were anesthetized with sodium pentobarbital (30 mg/kg body weight). The dogs were intubated and ventilated with room air. A peripheral venous catheter was inserted for the administration of fluids as necessary and for subsequent dipyridamole infusion. Both femoral arteries were cathet'erized for continuous aortic pressure monitoring and arterial blood sampling. The electrocardiogram (ECG) was also continuously recorded. The heart was then exposed by means of a left thoracotomy and suspended in a pericardial cradle. A left atrial catheter was inserted through the left atrial appendage for microsphere and isotope injection. The position of the catheter in the left atrium was confirmed by a left atrial pressure tracing. The proximal segment of the left anterior descending coronary artery was dissected free of the pericardium and a snare placed loosely around it for subsequent occlusion. 1992:1277-83 After stabilization of blood pressure and heart rate, 0.56 mg/kg of dipyridamole was infused intravenously for 4 min. At the end of this infusion, the left anterior descending coronary artery was occluded by the snare. After stabilization of the hemodynamic variables, micro spheres labeled with niobium (Nb)-95 (10 /LCi, DuPont, NEN products), 500 /LCi of Tc-99m sestamibi and 250 /Lei of thallium-201 were simultaneously injected into the left atrium. The arterial input function for microspheres was determined by arterial blood collection with a Harvard pump for 2 min. Arterial input function for both tracers was determined by serial arterial blood sampling for 2 min (group I = 2 dogs), 5 min (group II = 3 dogs) and 20 min (group III = 4 dogs). At the end of the blood sampling, the dogs were killed by injection of a saturated solution of potassium chloride. The heart was then quickly excised. Atrial, right ventricular and connective tissue was trimmed away. The It!ft ventricle was cut along the short axis into slices I mm thick. Each left ventricular slice was then sectioned into samples of approximately I g. Each myocardial sample was weighed. The activity in myocardial and blood samples was counted with use of a multichannel well counter (Packard model 5780). Energy windows were defined for Tc-99m (116 to 160 keY), thallium-201 (30 to 200 keY) and Nb-95 (710 to 820 keY). Blood and tissue samples were counted for Tc-99m immediately after the study. After allowing decay for Tc-99m (at least 12 half-lives of Tc-99m), the samples were counted for thallium-201 activity. The spillover of thallium-201 activity into the Tc-99m window was determined for each experiment and subtracted from Tc-99m sestamibi activity after correction for radioactivity decay. l\leasurement of myocardial blood flow. Myocardial blood flow was determined with the microsphere technique (25):
Experimental Protocol
where MBF is the myocardial blood flow (ml/min per g), Ct is the activity in the myocardial tissue sample (cpm/g), Fw is the reference blood flow pump withdrawal rate and Ab is the activity in the entire reference blood sample (cpm).
Measurement of absolute tracer retention. Absolute tracer retention was calculated as follows:
where R is the retention (ml/min per g) of the tracer (t), Ct is the radioactivity of the tracer in the myocardium (cpm/g), Cb is the arterial radioactivity concentration (cpm/ml) and it Cb( r) d( r) is the time-integral of Cb.
Measurement of percent maximal tracer retention. For further comparison of myocardial tracer retention the percent maximal retention for each tracer was also calculated as follows: where Rmax is the maximal tissue retention in an individual heart for the tracer and R is the tissue retention of the tracer for the considered myocardial segment. Measurement of normalized retention. For further comparison of tissue retention between the tracers, the normalized tissue retention was also calculated. For each dog the absolute myocardial retention of Tc-99m sestamibi and thallium-201 for each segment was plotted against the microsphere-determined blood flow. Each retention versus blood flow curve was fitted to the nonlinear function: R = a MBF (1 -e-bIMBF), [I] where R = retention, a and b = real constants, MBF = myocardial blood flow. Myocardial tissue retention values were calculated at a flow range of I, 2, 3, 4 and 5 ml/min per g based on the average of constants of the fitted equations for each group of dogs. The calculated retention was then expressed as a percent of retention determined at a flow rate of I mllmin per g. The increment of tissue retention was also calculated between each level of blood flow rate.
Statistical analysis. All values are expressed as mean value ± I SO. Blood pressure and heart rate at baseline after dipyridamole, before and after tracers and micro: spheres injection were compared by paired t test. Multivariate linear regression analysis was used to test the presence of a slope different from 0 for the relation between the retention and the microsphere-determined blood flow within three selected intervals of flow from I to 3, 3 to 5 and >5 mllmin per g. Individual dogs were treated as blocking variables. A p value >0.05 was considered not significant.
Results
Hemodynamic recordings. At baseline, before dipyridamole injection, the mean systolic pressure was 140 ± 22 mm Hg and the heart rate 160 ± 17 beats/min. After dipyridamole infusion, the systolic blood pressure decreased to 123 ± 29 mm Hg (p < 0.05) and the heart rate was 158 ± 25 beats/min (p = NS). At the time of tracer and microsphere injection, systolic blood pressure and heart rate were 123 ± 28 mm Hg and 159 ± 33 beats/min, respectively, and remained stable thereafter.
l'tlicrosphere-determined blood flow. Myocardial blood flow was determined in a total number of 114, 222 and 272 tissue samples in groups I, II and III, respectively. Microsphere-determined blood flow ranged from 0.04 to 7.13 ml/min per g in group I, from 0.01 to 5.51 ml/min per g in group II and from 0.02 to 7.1 I mllmin per g in group III.
Absolute myocardial retention. Absolute myocardial retention was calculated for each tissue sample. Table I shows the nonlinear fitted parameter estimates and correlation coefficients for all the experiments in the three groups. Figure 2A shows an individual example of retention flow relation for both tracers from each group. The absolute retention of thallium-20l was much greater than that of Tc-99m sestamibi. At 2 min after injection, absolute tissue retention for thallium-201 was 3.36 and 3.94 times greater than that for Tc-99m sestamibi at flow values of 2 and 5 mllmin per g, respectively. At 20 min after injection, it was 2.14 and 2.68 times greater than that for Tc-99m sestamibi at the same two levels of flow, respectively. The decrease in the thallium-201ITc-99m sestamibi retention ratio over time indicated greater back diffusion of thallium-201.
Percent maximal myocardial retention. Percent maximal myocardial retention was also calculated for each dog in the three groups. Figure 2B shows data of Figure 2A expressed in percent maximal myocardial retention. At 2 min after injection, the increase of relative retention for both tracers was linear in relation to blood flow over a wide flow range. The linear relation is lost at higher flow rates over time; Tc-99m sestamibi retention data were more scattered than were thallium-201 data at higher flow rates. MYOCARDIAL Normalized retention. The normalized retention expressed as a percent of retention at a blood flow of I mllmin per g is presented in Table 2 , which also shows the retention increments for both tracers between each level of blood flow. For each time point, increments of relative retention were always larger for thallium-201 than for Tc-99m sestamibi between the different blood flow levels over the entire range of blood flow. For both tracers, retention increments decreased as flow increased. Considering different amplitude of retention increment between each level of flow for Tc-99m sestamibi and thallium-201, a multivariate linear regression analysis was used to assess whether it may represent a different ability to evaluate blood flow changes for both tracers. The statistical analysis tested the presence of a slope different from 0 for the relation between the retention and the microsphere-determined blood flow within three selected intervals of flow. The slope was not different from 0 for Tc-99m sestamibi in comparison with thallium-201 for the intervals of flow of3 to 5 and >5 ml/min per g at 20 min after injection and for the interval of flow >5 ml/min per g at 5 min after injection (Table 3) .
Discussion
Absolute tissue retention of a tracer represents its ability to accumulate in the tissue as a function of delivery to the tissue. However, clinically more relevant is the relation of retention of the tracer to blood flow. This relation defines the accuracy of the tracer to determine tissue flow over a wide blood flow range. Extraction and retention of a tracer by tissue are determined by its diffusion or carrier-mediated transport across endothelial and sarcolemmal barriers, or both, and subsequent steps of transport or metabolism, or both. The delivery of the tracer is proportional to myocardial blood flow. As flow increases, the maximal initial extraction (peak extraction) for most tracers tends to decrease. This decrease of tracer extraction results in an underestimation of the "true" increase in blood flow as assessed by tissue tracer uptake. A high extraction or retention fraction indicates the suitability of a flow tracer to adequately assess higher flow rates, such as those encountered during pharmacologic coronary vasodilation. It is equally important that the tissue activity remain stable during the time of cardiac imaging which, in the case of Tc-99m sestamibi, usually begins 30 min after tracer injection. The biologic half-life of tracer in tissue depends on the clearance rate of the tracer from the tissue. Back diffusion may lead to underestimation of myocardial perfusion during delayed cardiac imaging. Thus, both initial extraction and subsequent retention by the myocardium define suitabIlity of a given tracer for flow studies.
Absolute and relative tracer retention. The present study demonstrates that absolute tissue retention of thallium-201 was greater than that of Tc-99m sestamibi. Tissue retention of both tracers underestimated blood flow at higher flow levels but thallium-201, as compared with Tc-99m sestamibi, was characterized by larger increments of relative tracer retention between different levels of blood flow. Our results are supported by previous studies. Recently, Edwards et al. (26) reported that thallium-201 and Tc-99m sestamibi relative uptake did not increase proportionally to blood flow during adenosine infusion; the increase in Tc-99m sestamibi was always less than that of thallium-20l. . Using isolated rabbit heart preparations and a multiindicator technique, Leppo and Meerdink (20) calculated peak extraction, net extraction (= retention) and capillary permeability surface area product for thallium-201 and Tc-99m sestamibi in a range of flow from 0.56 to 3.19 mlfmin per g. They showed that peak extraction and net extraction were greater for thallium-201 than for Tc-99m sestamibi. For both tracers the peak extraction and net extraction demonstrated a negatively sloped linear relation to blood flow. In our study the myocardial retention versus myocardial blood flow curves for both thallium-201 and Tc-99m sestamibi were empirically described by the function in equation I. The
MYOCARDIAL RETENTION OF PERFUSION TRACERS
Crone model (27) used by Leppo and Meerdink (20) , which assumes no back diffusion of tracer, is of similar form:
where PScap is the product of capillary permeability and surface area. Although a strict relation between the parameter band PS cannot be expected because our measurements do not account for the influence of tracer back flux, the decrease in b with time of measurement ( Table l) is consistent with increasing underestimation of tracer extraction (through PS) as the fraction of tracer undergoing back diffusion increases.
Pe"rcent maximal tracer retention. At 2 min after tracer injection, our study demonstrates a nearly linear relation between percent maximal retention of both thallium-20l and Tc-99m sestamibi and myocardial blood flow over a wide range of blood flow induced by intravenous infusion of dipyridamole. However, thallium-201 tissue retention was more closely related to blood flow than was Tc-99m sestamibi at higher flow rates; this early superiority of thallium-20 1 was lost at 20 "min after injection because of its greater back diffusion. Twenty minutes after injection, both tracers had greater underestimation of regional blood flow differences at higher flow rates. However, despite its greater back diffusion as compared with Tc-99m sestamibi, thallium-201 evaluated blood flow changes more efficiently.
Previously, using the isolated rabbit heart model, Marshall et al. (21) evaluated thallium-201 and Tc-99m sestamibi uptake (flow x net extraction) immediately and to and 30 min after injection for a range of flow of 0.5 to 3.5 mllmin per g. Immediately after thallium-2Ot injection, uptake of the tracer was closer to the line of identity for a range of flow between 0.5 and 2 mllmin per g. At flow rates above 2 mllmin per g, the uptake of both tracers tended to underestimate blood flow. The transport limitation on tracer uptake appeared to be more pronounced for Tc-99m sestamibi than for thallium-20l. At to and 30 min after injection, relative uptake of both tracers underestimated changes in flow rates over the range of perfusion rates. Our results are in agreement with these findings, although we used an in vivo model with dipyridamole infusion, inducing a larger range of blood flow.
Validity of the animal model. Dipyridamole infusion and left anterior descending coronary artery occlusion allow a wide range of blood flow rates to be obtained. By counting numerous myocardial segments, the relation between tracer retention and flow can be determined at the different flow levels over the wide flow range. In each time group, there is some variability in the fitted equations describing the data. This could be due in part to the different range of blood flow between the dogs: A small variation in the length and the position of the catheter in the left atrium c{)uld also modify the delivery time of the tracers to the myocardium early after injection.
In this study the dosages of Tc-99m sestamibi and thallium-201 were chosen for counting purposes. The injected doses were dependent on the maximal count rate of the well counter. Furthermore, because of simultaneous tracer injection, the higher doses of Tc-99m sestamibi minimized the relative spillover of thallium-201 activity into the Tc-99m sestamibi window at the time of counting. As thallium-201 activity was counted after decay of Tc-99m sestamibi, there was no spillover of Tc-99m activity into the thallium window. Because in vitro counting was used, it is unlikely that the chosen dosage for each tracer may have influenced the results of this study.
Clinical imaging implications. The clinical implication of the study is that thallium-201 tissue retention more closely represents myocardial blood flow changes than does that of Tc-99m sestamibi. Of course, this does not consider image quality related to physical properties of thallium-20 I, because the data were acquired in a well counter and not by an imaging technique. Furthermore, external detection of myocardial activity with use of a gamma camera may also be inferior in resolving differences of tracer retention corresponding to blood flow changes. Our results also imply that for both tracers early image acquisition minimizes the underestimation of blood flow differences at higher flow.
Several clinical studies (11, (13) (14) (15) (16) 28, 29) reported similar sensitivity and specificity for thallium-201 and Tc-99m sestamibi in the detection of coronary artery disease. These studies were based on evaluation of relative difference of regional tracer activity in the myocardium. For both tracers tomographic imaging, as compared with planar imaging, improved the detection of the diseased arteries. However, at present there is no clear evidence that Tc-99m sestamibi offers significant advantages over thallium-201 for the detection of coronary disease. The better image quality of Tc-99m sestamibi may be offset by less suitable physiologic characteristics of this flow tracer. Furthermore, no large clinical studies employing pharmacologic vasodilation have been performed comparing the diagnostic accuracy of Tc-99m sestamibi and thallium-201 for the detection of coronary artery disease, although recently Eisner et al. (30) compared the myocardial distribution of these tracers in dogs with partial and total coronary artery occlusion during adenosine infusion. Using a polar map display, they showed that Tc-99m sestamibi in comparison with thallium-201 underestimated the size of underperfused territories related to the partially occluded vessel. Inversely, the size of the defect determined by both tracers was similar after total coronary artery occlusion. Thus, these results also suggest that Tc99m sestamibi may be less accurate than thallium-201 in the detection of reduced coronary flow reserve in myocardial territories suspended by mild coronary artery stenosis during pharmacologic vasodilation.
Conclusions. Thallium-201 and Tc-99m sestamibi are characterized by different kinetic properties. Thallium-201 demonstrates greater absolute tissue retention than does Tc-99m sestamibi. Early after injection, there is a well maintained relation between the tissue retention of both tracers and blood flow, although retention of both tracers lAce Vol. 20 1992:1277-83 underestimates blood flow at higher flow rates. Overall, thallium-201 retention characteristics may allow better differentiation of regions with different coronary flow reserve. Additional clinical studies will have to compare Tc-99m sestamibi and thallium-201 accuracy for the detection of coronary disease during coronary pharmacologic vasodilation and determine whether Tc-99m sestamibi accuracy may be inferior to that of thallium-20 I in the detection of patients with mild coronary artery disease.
